首页 > 最新文献

Bjog-An International Journal of Obstetrics and Gynaecology最新文献

英文 中文
Intrapartum and postpartum antibiotic use in seven low- and middle-income countries: Findings from the A-PLUS trial 七个中低收入国家的产前和产后抗生素使用情况:A-PLUS试验结果。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-14 DOI: 10.1111/1471-0528.17930
Sarah Saleem, Haleema Yasmin, Janet L. Moore, Anum Rahim, Iram Shakeel, Adrien Lokangaka, Antoinette Tshefu, Melissa Bauserman, Musaku Mwenechanya, Elwyn Chomba, Shivaprasad S. Goudar, Avinash Kavi, Richard J. Derman, Nancy F. Krebs, Lester Figueroa, Manolo Mazariegos, Paul Nyongesa, Sherri Bucher, Fabian Esamai, Archana Patel, Manjushree Waikar, Poonam Shivkumar, Patricia L. Hibberd, William A. Petri, Sk Masum Billah, Rashidul Haque, Waldemar A. Carlo, Alan Tita, Marion Koso-Thomas, Jennifer Hemingway-Foday, Elizabeth M. McClure, Robert L. Goldenberg
<div> <section> <h3> Objective</h3> <p>To describe the intrapartum and postpartum use of non-study antibiotics in low- and middle-income countries (LMICs) during the double-blinded NICHD Global Network Azithromycin in Labor (A-PLUS) trial.</p> </section> <section> <h3> Design</h3> <p>The antibiotic use sub-study was a planned prospective, observational sub-study of the A-PLUS trial.</p> </section> <section> <h3> Settings</h3> <p>The study was carried out in hospitals or health centres affiliated with eight sites of the Global Network for Women's and Children's Health Research (Global Network) in seven countries: Bangladesh, Pakistan, India (two sites), Kenya, Zambia, The Democratic Republic of the Congo (DRC) and Guatemala.</p> </section> <section> <h3> Population</h3> <p>Totally, 29 278 pregnant women enrolled in the A-PLUS trial.</p> </section> <section> <h3> Methods</h3> <p>We collected data on 29 278 pregnant women admitted to a facility for delivery related to non-study antibiotic use overall and during three time periods: (1) in the facility prior to delivery, (2) after delivery until facility discharge and (3) after discharge to 42 days post-partum.</p> </section> <section> <h3> Main Outcome Measures</h3> <p>Non-study antibiotic use overall and for treatment or prophylaxis by the site during the three time periods.</p> </section> <section> <h3> Results</h3> <p>Of the 29 278 women in the study, 5020 (17.1%; 95% CI 16.7%–17.6%) received non-study antibiotics in the facility prior to delivery, 11 956 (40.8%; 95% CI 40.3%–41.4%) received non-study antibiotics in the facility after delivery, and 13 390 (47.6%; 95% CI 47.0%–48.2%) women received non-study antibiotics after delivery and after facility discharge. Antibiotics were prescribed more often among women in the Asian and Guatemalan sites than in the African sites. In the three time-periods, among those receiving antibiotics, prophylaxis was the indication in 82.3%, 97.7% and 90.7% of the cases, respectively. The type of antibiotics used varied substantially by time-period and site, but generally, penicillin-type drugs, cephalosporin-type drugs and metronidazole were used more frequently than other types.</p> </section> <section> <h3> Conclusions</h3> <p>Across the eight sites of the Global Network, in the facility before delivery, and in the post-partum p
目的描述中低收入国家(LMICs)在国家儿童疾病防治中心(NICHD)全球网络产程中阿奇霉素双盲试验(A-PLUS)期间产前和产后使用非试验抗生素的情况:抗生素使用子研究是 A-PLUS 试验的一项计划性前瞻性观察子研究:研究在七个国家的八个全球妇幼健康研究网络(全球网络)下属医院或保健中心进行:孟加拉国、巴基斯坦、印度(两个地点)、肯尼亚、赞比亚、刚果民主共和国和危地马拉:方法:我们收集了 29 278 名参加 A-PLUS 试验的孕妇的数据:我们收集了 29 278 名在医疗机构分娩的孕妇的数据,这些数据涉及非研究抗生素使用的总体情况和三个时间段:(1) 分娩前在医疗机构,(2) 分娩后至出院,(3) 出院后至产后 42 天:主要结果测量指标:非研究抗生素的总体使用情况,以及三个时间段内各医疗机构治疗或预防抗生素的使用情况:在参与研究的 29 278 名产妇中,有 5020 人(17.1%;95% CI 16.7%-17.6%)在分娩前在医疗机构接受了非研究抗生素治疗,有 11 956 人(40.8%;95% CI 40.3%-41.4%)在分娩后在医疗机构接受了非研究抗生素治疗,有 13 390 人(47.6%;95% CI 47.0%-48.2%)在分娩后和出院后接受了非研究抗生素治疗。亚洲和危地马拉地区的产妇比非洲地区的产妇更常使用抗生素。在这三个时间段内,接受抗生素治疗的病例中,分别有 82.3%、97.7% 和 90.7% 的病例以预防为主。不同时期和不同地点使用的抗生素种类差别很大,但一般来说,青霉素类药物、头孢菌素类药物和甲硝唑的使用频率高于其他类型的抗生素:在全球网络的八个地点中,在分娩前、分娩后出院前和出院后,抗生素的使用频率很高,但不同地点和不同时间段的使用情况差异很大。
{"title":"Intrapartum and postpartum antibiotic use in seven low- and middle-income countries: Findings from the A-PLUS trial","authors":"Sarah Saleem,&nbsp;Haleema Yasmin,&nbsp;Janet L. Moore,&nbsp;Anum Rahim,&nbsp;Iram Shakeel,&nbsp;Adrien Lokangaka,&nbsp;Antoinette Tshefu,&nbsp;Melissa Bauserman,&nbsp;Musaku Mwenechanya,&nbsp;Elwyn Chomba,&nbsp;Shivaprasad S. Goudar,&nbsp;Avinash Kavi,&nbsp;Richard J. Derman,&nbsp;Nancy F. Krebs,&nbsp;Lester Figueroa,&nbsp;Manolo Mazariegos,&nbsp;Paul Nyongesa,&nbsp;Sherri Bucher,&nbsp;Fabian Esamai,&nbsp;Archana Patel,&nbsp;Manjushree Waikar,&nbsp;Poonam Shivkumar,&nbsp;Patricia L. Hibberd,&nbsp;William A. Petri,&nbsp;Sk Masum Billah,&nbsp;Rashidul Haque,&nbsp;Waldemar A. Carlo,&nbsp;Alan Tita,&nbsp;Marion Koso-Thomas,&nbsp;Jennifer Hemingway-Foday,&nbsp;Elizabeth M. McClure,&nbsp;Robert L. Goldenberg","doi":"10.1111/1471-0528.17930","DOIUrl":"10.1111/1471-0528.17930","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To describe the intrapartum and postpartum use of non-study antibiotics in low- and middle-income countries (LMICs) during the double-blinded NICHD Global Network Azithromycin in Labor (A-PLUS) trial.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The antibiotic use sub-study was a planned prospective, observational sub-study of the A-PLUS trial.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Settings&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The study was carried out in hospitals or health centres affiliated with eight sites of the Global Network for Women's and Children's Health Research (Global Network) in seven countries: Bangladesh, Pakistan, India (two sites), Kenya, Zambia, The Democratic Republic of the Congo (DRC) and Guatemala.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Totally, 29 278 pregnant women enrolled in the A-PLUS trial.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We collected data on 29 278 pregnant women admitted to a facility for delivery related to non-study antibiotic use overall and during three time periods: (1) in the facility prior to delivery, (2) after delivery until facility discharge and (3) after discharge to 42 days post-partum.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Non-study antibiotic use overall and for treatment or prophylaxis by the site during the three time periods.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Of the 29 278 women in the study, 5020 (17.1%; 95% CI 16.7%–17.6%) received non-study antibiotics in the facility prior to delivery, 11 956 (40.8%; 95% CI 40.3%–41.4%) received non-study antibiotics in the facility after delivery, and 13 390 (47.6%; 95% CI 47.0%–48.2%) women received non-study antibiotics after delivery and after facility discharge. Antibiotics were prescribed more often among women in the Asian and Guatemalan sites than in the African sites. In the three time-periods, among those receiving antibiotics, prophylaxis was the indication in 82.3%, 97.7% and 90.7% of the cases, respectively. The type of antibiotics used varied substantially by time-period and site, but generally, penicillin-type drugs, cephalosporin-type drugs and metronidazole were used more frequently than other types.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Across the eight sites of the Global Network, in the facility before delivery, and in the post-partum p","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"72-80"},"PeriodicalIF":4.7,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ChatGPT in a gynaecologic oncology multidisciplinary team tumour board: A feasibility study 妇科肿瘤多学科小组肿瘤委员会的 ChatGPT:可行性研究。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-14 DOI: 10.1111/1471-0528.17929
Gabriel Levin, Walter Gotlieb, Pedro Ramirez, Raanan Meyer, Yoav Brezinov
<p>The practical medical use of artificial intelligence is rapidly progressing. Specifically, the application of ChatGPT was explored in medical education and even medical clinical data evaluation.<span><sup>1, 2</sup></span> Tumour board is an integral and pivotal part of patient treatment and management in gynaecologic oncology.<span><sup>3</sup></span> It entails the processing of various pathological and clinical parameters, coupled with the familiarity with treatment guidelines in accordance with the various parameters. The participation of ChatGPT in breast cancer tumour board was previously studied, with contrasting results.<span><sup>4, 5</sup></span> We aim to study the feasibility of ChatGPT (Versions 3.5 and 4) as a support tool for endometrial cancer (EC) and ovarian cancer (OC) according to the NCCN and ESGO guidelines.</p><p>Ten EC cases and ten OC cases were fabricated based on experience of authors pertaining to the most complex scenarios discussed in real practice. For EC the following data was formulated: age, histology, stage, grade, lymphovascular space invasion, tumour size and molecular classification—MMR, p53 and POLE mutation status. For OC, the following data was formulated: age, histology and stage.</p><p>We created a new account for ChatGPT 3.5 and purchased and created an account for ChatGPT 4. We used generic prompts for all the cases. The ChatGPT 3.5 and ChatGPT 4 prompt are described (Appendix S1).</p><p>For each tumour board case, we accessed the NCCN and ESGO guidelines separately and recorded their recommendation. All ChatGPT recommendations were judged as correct or incorrect by two independent reviewers (G.L. and Y.B.). Data analysis is described in detail in the Appendix S1.</p><p>We used SPSS 29 for the statistical analysis. As no patient information was used—no ethical board review was needed for this study.</p><p>There were ten cases of EC cancer, stages IA-IIIC with four different histology, and ten cases of OC stages IA-IC3 with five different histology. ChatGPT 3.5 was unable to give a concrete recommendation, and ChatGPT 4 gave a recommendation to all cases. No disagreements between reviewers were noted for all 40 evaluations.</p><p>The rate of correct recommendations was 70% (14/20) for NCCN guidelines and 60% (12/20) for ESGO guidelines (<i>p</i> = 0.512). (Table 1). There were 55% (11/20) of cases with correct recommendations for both guidelines, 20% (4/20) of cases in which a correct recommendation was given only according to one guideline (Figure S1), and 25% (5/20) of cases in which an incorrect recommendation was given. Of those with an incorrect recommendation, 80% (4/5) were EC, stages IA-II, of all histology, and one case of OC, stage IA. Of the four single guidelines correct recommendations, all were EC, with three incorrect recommendations according to ESGO guidelines, including the only two cases with a positive POLE mutation. OC had higher complete correct recommendation as compared to EC
人工智能的实际医疗应用正在迅速发展。具体而言,探讨了ChatGPT在医学教育乃至医学临床数据评价中的应用。1,2肿瘤板是妇科肿瘤患者治疗和管理中不可或缺的关键部分它需要处理各种病理和临床参数,再加上熟悉根据各种参数的治疗指南。ChatGPT参与乳腺癌肿瘤治疗的研究之前有过对比结果。我们的目标是根据NCCN和ESGO指南,研究ChatGPT(版本3.5和版本4)作为子宫内膜癌(EC)和卵巢癌(OC)支持工具的可行性。10个EC案例和10个OC案例是根据作者在实际实践中讨论的最复杂场景的经验捏造的。对于EC,制定了以下数据:年龄,组织学,分期,分级,淋巴血管间隙侵犯,肿瘤大小和分子分类- mmr, p53和POLE突变状态。对于OC,制定以下数据:年龄,组织学和分期。我们为ChatGPT 3.5创建了一个新帐户,并为ChatGPT 4购买并创建了一个帐户。我们对所有情况都使用了通用提示。ChatGPT 3.5和ChatGPT 4提示符描述(附录S1)。对于每个肿瘤板病例,我们分别查阅了NCCN和ESGO指南,并记录了他们的建议。所有的ChatGPT建议都由两个独立的审稿人(G.L.和Y.B.)判断为正确或不正确。数据分析在附录S1中有详细描述。采用SPSS 29进行统计分析。由于没有使用患者信息,因此本研究不需要伦理委员会的审查。10例EC癌,分期为IA-IIIC,有4种不同的组织学,10例OC分期为IA-IC3,有5种不同的组织学。ChatGPT 3.5无法给出具体的建议,ChatGPT 4给出了所有案例的建议。所有40项评价均未发现评审人员之间存在分歧。NCCN指南推荐正确率为70% (14/20),ESGO指南推荐正确率为60% (12/20)(p = 0.512)。(表1)。55%(11/20)的病例对两个指南都给出了正确的建议,20%(4/20)的病例只根据一个指南给出了正确的建议(图S1), 25%(5/20)的病例给出了错误的建议。在不正确推荐的患者中,80%(4/5)为所有组织学分期IA- ii期EC, 1例为IA期OC。在四个单一指南正确的建议中,所有建议都是EC,根据ESGO指南有三个不正确的建议,包括仅有的两个阳性POLE突变病例。与EC相比,OC有更高的完全正确推荐(90%对20%,p = 0.005)。ChatGPT 4辅助治疗建议见表S1和表S2。在这项可行性研究中,我们发现在三分之二的评估病例中,ChatGPT 4提供了正确的建议,然而在25%的病例中,主要是子宫内膜癌,有一个不正确的建议。子宫内膜癌的正确建议完成率较低,可能是由于早期阶段、组织学和分级的复杂性以及子宫内膜癌分子特征的整合。需要更多的研究来评估该工具的可信性并为其潜在用途配置协议。然而,在大量诊所的环境中,或者在专业知识资源有限的地区,这些工具可能有助于医生维持循证护理。进一步的研究应关注ChatGPT对正在进行的临床试验的熟悉程度,以评估可能的患者资格。我们的局限性包括研究的病例数量少,并且我们的研究仅限于子宫内膜癌和卵巢癌。此外,我们使用了通用的ChatGPT工具,没有对我们的数据进行任何特定的培训。此外,我们在这项研究中只使用了两个人工智能平台,这可能会限制我们结果的普遍性。重要的是,我们没有将人工智能生成的建议与多学科肿瘤委员会的建议进行比较,后者是实际实践中的“黄金标准”。最后,所有的数据都是正确的,直到本文写作的时间。由于ChatGPT是一个大型的语言模型,他不断地根据提示进行训练,并且他的输出可能会随着时间的推移而变化和发展。鼓励未来对妇科肿瘤的前瞻性现实生活评估,以更好地描述人工智能工具的优点和缺陷及其对实践的影响。Gabriel Levin:构思,设计,获取数据,分析和解释数据,起草文章,批准最终版本。Walter gottlieb:获取数据,对文章进行关键性修订,批准最终版本。 Pedro Ramirez:获取数据,对文章进行关键性修改,批准最终版本。Raanan Meyer:获取数据,对文章进行关键性修改,批准最终版本。Yoav Brezinov:构思和设计,分析和解释数据,对文章进行批判性修改,批准最终版本。本研究未获得外部资助,作者报告无利益冲突。由于没有使用患者信息,因此本研究不需要伦理委员会的审查。
{"title":"ChatGPT in a gynaecologic oncology multidisciplinary team tumour board: A feasibility study","authors":"Gabriel Levin,&nbsp;Walter Gotlieb,&nbsp;Pedro Ramirez,&nbsp;Raanan Meyer,&nbsp;Yoav Brezinov","doi":"10.1111/1471-0528.17929","DOIUrl":"10.1111/1471-0528.17929","url":null,"abstract":"&lt;p&gt;The practical medical use of artificial intelligence is rapidly progressing. Specifically, the application of ChatGPT was explored in medical education and even medical clinical data evaluation.&lt;span&gt;&lt;sup&gt;1, 2&lt;/sup&gt;&lt;/span&gt; Tumour board is an integral and pivotal part of patient treatment and management in gynaecologic oncology.&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt; It entails the processing of various pathological and clinical parameters, coupled with the familiarity with treatment guidelines in accordance with the various parameters. The participation of ChatGPT in breast cancer tumour board was previously studied, with contrasting results.&lt;span&gt;&lt;sup&gt;4, 5&lt;/sup&gt;&lt;/span&gt; We aim to study the feasibility of ChatGPT (Versions 3.5 and 4) as a support tool for endometrial cancer (EC) and ovarian cancer (OC) according to the NCCN and ESGO guidelines.&lt;/p&gt;&lt;p&gt;Ten EC cases and ten OC cases were fabricated based on experience of authors pertaining to the most complex scenarios discussed in real practice. For EC the following data was formulated: age, histology, stage, grade, lymphovascular space invasion, tumour size and molecular classification—MMR, p53 and POLE mutation status. For OC, the following data was formulated: age, histology and stage.&lt;/p&gt;&lt;p&gt;We created a new account for ChatGPT 3.5 and purchased and created an account for ChatGPT 4. We used generic prompts for all the cases. The ChatGPT 3.5 and ChatGPT 4 prompt are described (Appendix S1).&lt;/p&gt;&lt;p&gt;For each tumour board case, we accessed the NCCN and ESGO guidelines separately and recorded their recommendation. All ChatGPT recommendations were judged as correct or incorrect by two independent reviewers (G.L. and Y.B.). Data analysis is described in detail in the Appendix S1.&lt;/p&gt;&lt;p&gt;We used SPSS 29 for the statistical analysis. As no patient information was used—no ethical board review was needed for this study.&lt;/p&gt;&lt;p&gt;There were ten cases of EC cancer, stages IA-IIIC with four different histology, and ten cases of OC stages IA-IC3 with five different histology. ChatGPT 3.5 was unable to give a concrete recommendation, and ChatGPT 4 gave a recommendation to all cases. No disagreements between reviewers were noted for all 40 evaluations.&lt;/p&gt;&lt;p&gt;The rate of correct recommendations was 70% (14/20) for NCCN guidelines and 60% (12/20) for ESGO guidelines (&lt;i&gt;p&lt;/i&gt; = 0.512). (Table 1). There were 55% (11/20) of cases with correct recommendations for both guidelines, 20% (4/20) of cases in which a correct recommendation was given only according to one guideline (Figure S1), and 25% (5/20) of cases in which an incorrect recommendation was given. Of those with an incorrect recommendation, 80% (4/5) were EC, stages IA-II, of all histology, and one case of OC, stage IA. Of the four single guidelines correct recommendations, all were EC, with three incorrect recommendations according to ESGO guidelines, including the only two cases with a positive POLE mutation. OC had higher complete correct recommendation as compared to EC ","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"99-101"},"PeriodicalIF":4.7,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17929","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing HPV vaccination and education to reduce vaginal cancer incidence. 加强 HPV 疫苗接种和教育,降低阴道癌发病率。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-12 DOI: 10.1111/1471-0528.17935
Tomoyuki Kawada
{"title":"Enhancing HPV vaccination and education to reduce vaginal cancer incidence.","authors":"Tomoyuki Kawada","doi":"10.1111/1471-0528.17935","DOIUrl":"https://doi.org/10.1111/1471-0528.17935","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obstetric anal sphincter injuries during instrumental vaginal delivery 器械阴道分娩时产科肛门括约肌损伤。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-12 DOI: 10.1111/1471-0528.17931
Prathamesh Lanjewar, Avir Sarkar
{"title":"Obstetric anal sphincter injuries during instrumental vaginal delivery","authors":"Prathamesh Lanjewar,&nbsp;Avir Sarkar","doi":"10.1111/1471-0528.17931","DOIUrl":"10.1111/1471-0528.17931","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"102"},"PeriodicalIF":4.7,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141972283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnetic resonance imaging and clinical features of Mayer–Rokitansky–Küster–Hauser syndrome: A 10-year review from a dedicated specialist centre Mayer-Rokitansky-Küster-Hauser综合征的磁共振成像和临床特征:来自一家专科中心的 10 年回顾。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-12 DOI: 10.1111/1471-0528.17928
Nina Cooper, Maya Al-Memar, Kristofer Linton-Reid, Keith Edmonds, Gillian Rose, Nuala Dixon, Cillian McNamara, Christina Fotopoulou, Katherine Van Ree, Nishat Bharwani

Objective

To correlate the clinical history with imaging findings of women with Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome.

Design

Retrospective cohort study.

Setting

A UK IOTA and ESGO-certified tertiary referral centre for disorders of reproductive development.

Population

All patients with a diagnosis of MRKH and who had undergone an MRI pelvis between 1 January 2011 and 31 April 2021 were included.

Methods

MRI images were analysed by specialist gynaecological radiologists. Clinical data was extracted from an electronic patient record system. Statistical analysis was computed in R (version 4.1.2), R base stats package and ggstatsplot (v0.5.0).

Main Outcome Measures

Clinical history and predefined imaging features.

Results

One hundred and thirty-four patients were included. Median age at MRI was 18 years (10–64 years). Half (48.2%) of women presenting had a history of pain, most often abdominal (84.6%) or vaginal (9.2%). Remnants were identified in 91.8% of women (n = 123). 4.5% of women had imaging features of endometriosis (n = 6). Women with a functional remnants were significantly more likely to experience pain (p < 0.001). Pain history was not strongly associated with ectopic ovarian position. Common gynaecological pathology such as endometriosis, ovarian cysts and fibroids were also identified.

Conclusions

We identify that majority of women with MRKH will have uterine remnants with a connecting fibrous band, and an ectopic ovarian position 44.0% of cases. Abdominal pain was significantly associated with functional remnants on MRI. Further work is required to identify how other gynaecological pathology impacts women with MRKH.

目的将Mayer-Rokitansky-Küster-Hauser(MRKH)综合征女性患者的临床病史与影像学检查结果联系起来:设计:回顾性队列研究:英国一家经 IOTA 和 ESGO 认证的生殖发育障碍三级转诊中心:方法:所有确诊为 MRKH 并在 2011 年 1 月 1 日至 2021 年 4 月 31 日期间接受过磁共振骨盆成像检查的患者均纳入研究范围:磁共振成像图像由专业妇科放射医师进行分析。临床数据从电子病历系统中提取。统计分析使用 R(4.1.2 版)、R base stats 软件包和 ggstatsplot(v0.5.0)进行计算:临床病史和预定义的影像学特征:结果:共纳入 134 名患者。核磁共振成像时的中位年龄为 18 岁(10-64 岁)。半数(48.2%)女性患者有疼痛病史,多为腹痛(84.6%)或阴道疼痛(9.2%)。91.8%的妇女(n = 123)发现了残留物。4.5%的妇女有子宫内膜异位症的影像学特征(n = 6)。有功能性残留物的妇女更容易感到疼痛(p 结论:有功能性残留物的妇女更容易感到疼痛:我们发现,大多数 MRKH 妇女都会有子宫残留和连接纤维带,44.0% 的病例有异位卵巢。腹痛与核磁共振成像中的功能性残留物有明显关联。还需要进一步研究其他妇科病变对 MRKH 妇女的影响。
{"title":"Magnetic resonance imaging and clinical features of Mayer–Rokitansky–Küster–Hauser syndrome: A 10-year review from a dedicated specialist centre","authors":"Nina Cooper,&nbsp;Maya Al-Memar,&nbsp;Kristofer Linton-Reid,&nbsp;Keith Edmonds,&nbsp;Gillian Rose,&nbsp;Nuala Dixon,&nbsp;Cillian McNamara,&nbsp;Christina Fotopoulou,&nbsp;Katherine Van Ree,&nbsp;Nishat Bharwani","doi":"10.1111/1471-0528.17928","DOIUrl":"10.1111/1471-0528.17928","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To correlate the clinical history with imaging findings of women with Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Retrospective cohort study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>A UK IOTA and ESGO-certified tertiary referral centre for disorders of reproductive development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Population</h3>\u0000 \u0000 <p>All patients with a diagnosis of MRKH and who had undergone an MRI pelvis between 1 January 2011 and 31 April 2021 were included.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>MRI images were analysed by specialist gynaecological radiologists. Clinical data was extracted from an electronic patient record system. Statistical analysis was computed in R (version 4.1.2), R base stats package and ggstatsplot (v0.5.0).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome Measures</h3>\u0000 \u0000 <p>Clinical history and predefined imaging features.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>One hundred and thirty-four patients were included. Median age at MRI was 18 years (10–64 years). Half (48.2%) of women presenting had a history of pain, most often abdominal (84.6%) or vaginal (9.2%). Remnants were identified in 91.8% of women (<i>n</i> = 123). 4.5% of women had imaging features of endometriosis (<i>n</i> = 6). Women with a functional remnants were significantly more likely to experience pain (<i>p</i> &lt; 0.001). Pain history was not strongly associated with ectopic ovarian position. Common gynaecological pathology such as endometriosis, ovarian cysts and fibroids were also identified.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>We identify that majority of women with MRKH will have uterine remnants with a connecting fibrous band, and an ectopic ovarian position 44.0% of cases. Abdominal pain was significantly associated with functional remnants on MRI. Further work is required to identify how other gynaecological pathology impacts women with MRKH.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"64-71"},"PeriodicalIF":4.7,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17928","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of hormone therapy on cardiovascular risk in postmenopausal women: Insights and recommendations. 激素疗法对绝经后妇女心血管风险的影响:见解和建议。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-09 DOI: 10.1111/1471-0528.17932
Luyang Su, Zeqing Du, Cuiqiao Meng
{"title":"The impact of hormone therapy on cardiovascular risk in postmenopausal women: Insights and recommendations.","authors":"Luyang Su, Zeqing Du, Cuiqiao Meng","doi":"10.1111/1471-0528.17932","DOIUrl":"https://doi.org/10.1111/1471-0528.17932","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
External validation of models to estimate gestational age in the second and third trimester using ultrasound: A prospective multicentre observational study 利用超声波估算第二和第三孕期胎龄模型的外部验证:前瞻性多中心观察研究。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-08 DOI: 10.1111/1471-0528.17922
Alice Self, Michael Schlussel, Gary S. Collins, Ferdinand Dhombres, Nicolas Fries, Georges Haddad, Laurent J. Salomon, Mona Massoud, Aris T. Papageorghiou
<div> <section> <h3> Objectives</h3> <p>Accurate assessment of gestational age (GA) is important at both individual and population levels. The most accurate way to estimate GA in women who book late in pregnancy is unknown. The aim of this study was to externally validate the accuracy of equations for GA estimation in late pregnancy and to identify the best equation for estimating GA in women who do not receive an ultrasound scan until the second or third trimester.</p> </section> <section> <h3> Design</h3> <p>This was a prospective, observational cross-sectional study.</p> </section> <section> <h3> Setting</h3> <p>57 prenatal care centres, France.</p> </section> <section> <h3> Participants</h3> <p>Women with a singleton pregnancy and a previous 11–14-week dating scan that gave the observed GA were recruited over an 8-week period. They underwent a standardised ultrasound examination at one time point during the pregnancy (15–43 weeks), measuring 12 foetal biometric parameters that have previously been identified as useful for GA estimation.</p> </section> <section> <h3> Main Outcome Measures</h3> <p>A total of 189 equations that estimate GA based on foetal biometry were examined and compared with GA estimation based on foetal CRL. Comparisons between the observed GA and the estimated GA were made using <i>R</i><sup>2</sup>, calibration slope and intercept. RMSE, mean difference and 95% range of error were also calculated.</p> </section> <section> <h3> Results</h3> <p>A total of 2741 pregnant women were examined. After exclusions, 2339 participants were included. In the 20 best performing equations, the intercept ranged from −0.22 to 0.30, the calibration slope from 0.96 to 1.03 and the RSME from 0.67 to 0.87. Overall, multiparameter models outperformed single-parameter models. Both the 95% range of error and mean difference increased with gestation. Commonly used models based on measurement of the head circumference alone were not amongst the best performing models and were associated with higher 95% error and mean difference.</p> </section> <section> <h3> Conclusions</h3> <p>We provide strong evidence that GA-specific equations based on multiparameter models should be used to estimate GA in late pregnancy. However, as all methods of GA assessment
目的:准确评估孕龄(GA)对个人和人群都很重要。估算孕晚期妇女孕龄的最准确方法尚不清楚。本研究旨在从外部验证孕晚期孕龄估算公式的准确性,并确定最佳公式,以估算在妊娠第二或第三个月才接受超声波扫描的妇女的孕龄:设计:这是一项前瞻性、观察性横断面研究:地点:法国 57 家产前护理中心:在为期 8 周的时间里,招募了单胎妊娠且之前在 11-14 周的孕期扫描中观察到胎儿性别的妇女。她们在孕期的一个时间点(15-43周)接受了标准化超声波检查,测量了12个胎儿生物测量参数,这些参数之前已被确认为有助于估计胎儿性别:主要结果测量:共研究了 189 个基于胎儿生物测量的 GA 估算方程,并与基于胎儿 CRL 的 GA 估算进行了比较。使用 R2、校准斜率和截距对观察到的 GA 与估计的 GA 进行比较。还计算了 RMSE、平均差和 95% 的误差范围:共有 2741 名孕妇接受了检查。排除后,共纳入 2339 名参与者。在 20 个表现最好的方程中,截距范围从-0.22 到 0.30,校准斜率从 0.96 到 1.03,RSME 从 0.67 到 0.87。总体而言,多参数模型优于单参数模型。95% 误差范围和平均差都随着妊娠期的增加而增加。仅以测量头围为基础的常用模型并不是表现最好的模型,其 95% 误差和平均差也较高:我们提供了强有力的证据,证明基于多参数模型的GA特异性方程应用于估计孕晚期的GA。然而,由于妊娠晚期的所有 GA 评估方法都与较大的预测间期有关,因此,改善早期产前超声检查的可及性仍是当务之急:本研究的提案及相应的方法学综述已在 PROSPERO 国际系统综述注册中心注册(注册号:CRD4201913776)。
{"title":"External validation of models to estimate gestational age in the second and third trimester using ultrasound: A prospective multicentre observational study","authors":"Alice Self,&nbsp;Michael Schlussel,&nbsp;Gary S. Collins,&nbsp;Ferdinand Dhombres,&nbsp;Nicolas Fries,&nbsp;Georges Haddad,&nbsp;Laurent J. Salomon,&nbsp;Mona Massoud,&nbsp;Aris T. Papageorghiou","doi":"10.1111/1471-0528.17922","DOIUrl":"10.1111/1471-0528.17922","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objectives&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Accurate assessment of gestational age (GA) is important at both individual and population levels. The most accurate way to estimate GA in women who book late in pregnancy is unknown. The aim of this study was to externally validate the accuracy of equations for GA estimation in late pregnancy and to identify the best equation for estimating GA in women who do not receive an ultrasound scan until the second or third trimester.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This was a prospective, observational cross-sectional study.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;57 prenatal care centres, France.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Participants&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Women with a singleton pregnancy and a previous 11–14-week dating scan that gave the observed GA were recruited over an 8-week period. They underwent a standardised ultrasound examination at one time point during the pregnancy (15–43 weeks), measuring 12 foetal biometric parameters that have previously been identified as useful for GA estimation.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A total of 189 equations that estimate GA based on foetal biometry were examined and compared with GA estimation based on foetal CRL. Comparisons between the observed GA and the estimated GA were made using &lt;i&gt;R&lt;/i&gt;&lt;sup&gt;2&lt;/sup&gt;, calibration slope and intercept. RMSE, mean difference and 95% range of error were also calculated.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A total of 2741 pregnant women were examined. After exclusions, 2339 participants were included. In the 20 best performing equations, the intercept ranged from −0.22 to 0.30, the calibration slope from 0.96 to 1.03 and the RSME from 0.67 to 0.87. Overall, multiparameter models outperformed single-parameter models. Both the 95% range of error and mean difference increased with gestation. Commonly used models based on measurement of the head circumference alone were not amongst the best performing models and were associated with higher 95% error and mean difference.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We provide strong evidence that GA-specific equations based on multiparameter models should be used to estimate GA in late pregnancy. However, as all methods of GA assessment ","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 13","pages":"1862-1873"},"PeriodicalIF":4.7,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17922","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delivering in or out of water, the OASI rates in the POOL cohort study are disturbingly high. 无论是否在水中分娩,POOL 队列研究中的 OASI 率都高得令人不安。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-08 DOI: 10.1111/1471-0528.17933
Jan Willem de Leeuw, Katariina Laine, Margareta Manresa, Sari Raisanen, Vladimir Kalis, Zdenĕk Rušavý, Renaud de Tayrac
{"title":"Delivering in or out of water, the OASI rates in the POOL cohort study are disturbingly high.","authors":"Jan Willem de Leeuw, Katariina Laine, Margareta Manresa, Sari Raisanen, Vladimir Kalis, Zdenĕk Rušavý, Renaud de Tayrac","doi":"10.1111/1471-0528.17933","DOIUrl":"https://doi.org/10.1111/1471-0528.17933","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel use of the rectus abdominus muscle flap for vaginal reconstruction in complex obstetric fistula repair: A case series 在复杂产科瘘修补术中使用腹直肌肌皮瓣重建阴道的新方法:病例系列。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-08 DOI: 10.1111/1471-0528.17926
Tulsi Patel, Rodger Brown, Ennet Chipungu, Michael Breen, Jennifer Draganchuk, Patrick Nampandeni, Awol Legesse, Jeffrey Wilkinson

Objective

Globally, obstetric fistula is a tragic outcome following obstructed labour. Failure of complex repair and post-operative incontinence are common. We describe an innovative surgical technique incorporating the rectus abdominus flap at the time of fistula repair.

Design

Retrospective case series.

Setting

Malawi, Fistula Care Centre.

Methods

Patients were followed for 3 months after discharge to determine continence and healing.

Results

Five of six patients were continent at 3 months and one was lost to follow-up by dry at a one month post-operative phone call. There were no major complications.

Conclusions

The rectus abdominus flap may be a useful adjunct to repair of complex obstetric fistula.

目的:在全球范围内,产科瘘是难产后的一种悲剧性后果。复杂修补失败和术后失禁是常见病。我们介绍了一种在瘘管修补时结合腹直肌皮瓣的创新手术技术:设计:回顾性病例系列:马拉维,瘘管护理中心:方法:患者出院后随访3个月,以确定其排便和愈合情况:结果:6 名患者中有 5 人在 3 个月后仍能继续排尿,1 人在术后 1 个月的电话随访中因干性失访。没有重大并发症:结论:腹直肌皮瓣可能是修复复杂产科瘘管的有效辅助手段。
{"title":"Novel use of the rectus abdominus muscle flap for vaginal reconstruction in complex obstetric fistula repair: A case series","authors":"Tulsi Patel,&nbsp;Rodger Brown,&nbsp;Ennet Chipungu,&nbsp;Michael Breen,&nbsp;Jennifer Draganchuk,&nbsp;Patrick Nampandeni,&nbsp;Awol Legesse,&nbsp;Jeffrey Wilkinson","doi":"10.1111/1471-0528.17926","DOIUrl":"10.1111/1471-0528.17926","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Globally, obstetric fistula is a tragic outcome following obstructed labour. Failure of complex repair and post-operative incontinence are common. We describe an innovative surgical technique incorporating the rectus abdominus flap at the time of fistula repair.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>Retrospective case series.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>Malawi, Fistula Care Centre.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Patients were followed for 3 months after discharge to determine continence and healing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Five of six patients were continent at 3 months and one was lost to follow-up by dry at a one month post-operative phone call. There were no major complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The rectus abdominus flap may be a useful adjunct to repair of complex obstetric fistula.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"6-11"},"PeriodicalIF":4.7,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The intergenerational association of preterm birth: A systematic review and meta-analysis 早产的代际关联:系统回顾和荟萃分析。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-07 DOI: 10.1111/1471-0528.17924
Abdulbasit Seid, Miranda S. Cumpston, Kedir Y. Ahmed, Habtamu Mellie Bizuayehu, Subash Thapa, Teketo Kassaw Tegegne, Abel F. Dadi, Daniel Bogale Odo, Desalegn Markos Shifti, Sewunet Admasu Belachew, Getiye Dejenu Kibret, Daniel Bekele Ketema, Zemenu Yohannes Kassa, Erkihun Amsalu, Meless G. Bore, Tahir Ahmed Hassen

Background

Around half of preterm births lack identifiable causes, indicating the need for further investigation to understand preterm birth risk factors. Existing studies on the intergenerational association of preterm birth showed inconsistency in effect size and direction.

Objective

This systematic review and meta-analysis aimed to review existing studies and provide comprehensive evidence on the intergenerational association of preterm births.

Search Strategy

We searched MEDLINE, Embase and Maternity and Infant Care databases, from the inception of each database to 04 April 2024.

Selection Criteria

Eligibility criteria included studies that reported on women who had given birth and had recorded information about a family history of preterm birth in one or both of the child's biological parents.

Data Collection and Analysis

Data were extracted by two independent reviewers. A random-effects model was used to compute pooled estimates using odds ratios.

Main Results

Sixteen eligible studies with a total of 2 271 612 mothers were included. The findings indicated a 1.44 (OR = 1.44, 95% CI: 1.34, 1.54) fold increase in odds of giving preterm births among women who were born preterm. Additionally, having a sibling born preterm (OR = 1.53, 95% CI: 1.24, 1.87) and having a partner born preterm (OR = 1.12, 95% CI: 1.01, 1.25) were associated with increased likelihood of giving preterm births among women.

Conclusion

The study revealed that women with a family history of preterm birth face an increased risk of giving preterm births. Screening pregnant women for a family history of preterm birth is essential, with those having a positive family history requiring closer follow-up.

背景:约有一半的早产缺乏可确定的原因,这表明需要进一步调查以了解早产的风险因素。现有关于早产代际关联的研究在效应大小和方向上存在不一致性:本系统综述和荟萃分析旨在回顾现有研究,为早产的代际关联提供全面证据:检索策略:我们检索了 MEDLINE、Embase 和母婴护理数据库,检索时间从各数据库建立之初至 2024 年 4 月 4 日:资格标准包括对分娩妇女进行报道的研究,这些研究记录了孩子的亲生父母一方或双方有早产家族史的信息:数据由两名独立审查员提取。采用随机效应模型,使用几率比计算汇总估计值:主要结果:16 项符合条件的研究共纳入了 2 271 612 名母亲。研究结果表明,早产妇女的早产几率增加了 1.44 倍(OR = 1.44,95% CI:1.34,1.54)。此外,有早产兄弟姐妹(OR = 1.53,95% CI:1.24,1.87)和有早产伴侣(OR = 1.12,95% CI:1.01,1.25)的妇女早产的可能性也会增加:这项研究表明,有早产家族史的妇女早产的风险更高。对有早产家族史的孕妇进行筛查是非常必要的,有阳性家族史的孕妇需要更密切的随访。
{"title":"The intergenerational association of preterm birth: A systematic review and meta-analysis","authors":"Abdulbasit Seid,&nbsp;Miranda S. Cumpston,&nbsp;Kedir Y. Ahmed,&nbsp;Habtamu Mellie Bizuayehu,&nbsp;Subash Thapa,&nbsp;Teketo Kassaw Tegegne,&nbsp;Abel F. Dadi,&nbsp;Daniel Bogale Odo,&nbsp;Desalegn Markos Shifti,&nbsp;Sewunet Admasu Belachew,&nbsp;Getiye Dejenu Kibret,&nbsp;Daniel Bekele Ketema,&nbsp;Zemenu Yohannes Kassa,&nbsp;Erkihun Amsalu,&nbsp;Meless G. Bore,&nbsp;Tahir Ahmed Hassen","doi":"10.1111/1471-0528.17924","DOIUrl":"10.1111/1471-0528.17924","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Around half of preterm births lack identifiable causes, indicating the need for further investigation to understand preterm birth risk factors. Existing studies on the intergenerational association of preterm birth showed inconsistency in effect size and direction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This systematic review and meta-analysis aimed to review existing studies and provide comprehensive evidence on the intergenerational association of preterm births.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Search Strategy</h3>\u0000 \u0000 <p>We searched MEDLINE, Embase and Maternity and Infant Care databases, from the inception of each database to 04 April 2024.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Selection Criteria</h3>\u0000 \u0000 <p>Eligibility criteria included studies that reported on women who had given birth and had recorded information about a family history of preterm birth in one or both of the child's biological parents.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Collection and Analysis</h3>\u0000 \u0000 <p>Data were extracted by two independent reviewers. A random-effects model was used to compute pooled estimates using odds ratios.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Results</h3>\u0000 \u0000 <p>Sixteen eligible studies with a total of 2 271 612 mothers were included. The findings indicated a 1.44 (OR = 1.44, 95% CI: 1.34, 1.54) fold increase in odds of giving preterm births among women who were born preterm. Additionally, having a sibling born preterm (OR = 1.53, 95% CI: 1.24, 1.87) and having a partner born preterm (OR = 1.12, 95% CI: 1.01, 1.25) were associated with increased likelihood of giving preterm births among women.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The study revealed that women with a family history of preterm birth face an increased risk of giving preterm births. Screening pregnant women for a family history of preterm birth is essential, with those having a positive family history requiring closer follow-up.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"18-26"},"PeriodicalIF":4.7,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17924","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141903506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bjog-An International Journal of Obstetrics and Gynaecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1